BioXcel Therapeutics (BTAI) Revenue (2022 - 2026)
BioXcel Therapeutics (BTAI) recorded quarterly Revenue of $206000.0 in Q1 2026, down 19.53% quarter-over-quarter from $256000.0 in Q4 2025, and up 22.62% on a YoY basis from $168000.0 in Q1 2025.
BioXcel Therapeutics (BTAI) Revenue (2022 - 2026) Analysis & Trends
BioXcel Therapeutics' Revenue history runs 5 years deep, the most recent figure standing at $206000.0 for Q1 2026.
- In Q1 2026, Revenue rose 22.62% year-over-year to $206000.0; the TTM figure through Mar 2026 stood at $680000.0 (down 63.28% YoY), while the FY2025 annual figure was $642000.0, down 71.67% from the prior year.
- Revenue was $206000.0 for Q1 2026 at BioXcel Therapeutics, down from $256000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $1.1 million in Q2 2024 to a low of $98000.0 in Q3 2025.
- Historically, Revenue has averaged $324600.0 across 5 years, with a median of $238000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Revenue jumped 182.52% in 2024, then sank 89.13% in 2025.
- A 5-year view of Revenue shows it stood at $238000.0 in 2022, then surged by 57.98% to $376000.0 in 2023, then dropped by 2.66% to $366000.0 in 2024, then slumped by 30.05% to $256000.0 in 2025, then fell by 19.53% to $206000.0 in 2026.
- The last three Revenue figures came in at $206000.0 (Q1 2026), $256000.0 (Q4 2025), and $98000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.98 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.26 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 781.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 67.54 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 814.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.37 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 39.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 608.10 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 377.33 Mn |
| 10 | BioXcel Therapeutics | 25.46 Mn | 25.46 Mn | -77,000.00 | 206,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 120,000.00 |
| Mar 31, 2025 | 168,000.00 |
| Dec 31, 2024 | 366,000.00 |
| Sep 30, 2024 | 214,000.00 |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 582,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 341,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | 206,000.00 |
| Dec 31, 2022 | 238,000.00 |
| Sep 30, 2022 | 137,000.00 |